No Data
Express News | CASI Pharmaceuticals Inc Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing
CASI Pharmaceuticals Faces Evomela License Termination Dispute
Express News | CASI Pharmaceuticals: On Dec 13, Got Termination Process Letter for License of Evomela From Acrotech Biopharma
Aviation Safety Solutions and Corporate Aviation Security International Join Forces to Fill Needed Gap in Aviation Safety and Security
Earnings Flash (CASI) CASI PHARMACEUTICALS Reports Q3 Revenue $7.8M
CASI Pharmaceuticals Reports Q3 Results
Unlock the Full List
action. 
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
